Review




Structured Review

Spatial Transcriptomics Inc slide-seqv2
Slide Seqv2, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2/product/Spatial Transcriptomics Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 - by Bioz Stars, 2026-04
90/100 stars

Images



Similar Products

96
Broad Clinical Labs mouse hippocampus slide seqv2 data10
Mouse Hippocampus Slide Seqv2 Data10, supplied by Broad Clinical Labs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse hippocampus slide seqv2 data10/product/Broad Clinical Labs
Average 96 stars, based on 1 article reviews
mouse hippocampus slide seqv2 data10 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

95
TaKaRa slide seqv2 kit
Slide Seqv2 Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide seqv2 kit/product/TaKaRa
Average 95 stars, based on 1 article reviews
slide seqv2 kit - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc slide-seqv2
Slide Seqv2, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2/product/Spatial Transcriptomics Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc slide-seqv2 reagents
Slide Seqv2 Reagents, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2 reagents/product/Spatial Transcriptomics Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 reagents - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Broad Institute Inc slide-seqv2 mouse cerebellar data
Slide Seqv2 Mouse Cerebellar Data, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2 mouse cerebellar data/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 mouse cerebellar data - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Broad Institute Inc slide-seqv2 mouse cerebellum dataset
Slide Seqv2 Mouse Cerebellum Dataset, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2 mouse cerebellum dataset/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 mouse cerebellum dataset - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Broad Institute Inc slide-seqv2
(A) Experimental plan to study B cell differentiation in Pc AS-infected mice, with or without anti-malarial drug treatment, sorting CD19 + B220 int-hi IgD lo splenic B cells at various timepoints p.i. to perform droplet-based, paired single cell RNA and BCR sequencing. (B) Annotated combined UMAP of all mice, treatments and timepoints after high-dimensional reduction and clustering (left), with quantitation (right) of the proportion of selected, annotated B cells over the course of Pc AS infection (no drug treatment). (C) Sub-clustering of the GC cluster identifies distinct DZp, DZd, LZ/DZ and LZ GC B cell clusters as indicated in the dot plot of canonical markers and gene signatures of known GC B cell subsets. Also shown is quantitation of different GC B cell populations over time. RCTD spatial deconvolution of GC B cell populations on a day 30, Plasmodium infected spleen using <t>Slide-seqV2</t> spatial transcriptomics (right). (D) Median Aicda gene expression in GC B cell subsets and naive B cells as negative control. (E) Median Aicda expression shown overtime, with or without anti-malarial treatment in DZd and DZp GC B cells. (F) Somatic hypermutation analysis of GC B cell BCRs and isotype usage overtime, split by treatment, showing mutation rates for both treatments. Median number of mutations for each treatment and timepoint indicated in white. Data in B-C are shown as mean ± S.D. and analysed by one-way ANOVA with Tukey’s multiple comparisons test of n = 3 biological replicates. * p < 0.05.
Slide Seqv2, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slide-seqv2/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
slide-seqv2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


(A) Experimental plan to study B cell differentiation in Pc AS-infected mice, with or without anti-malarial drug treatment, sorting CD19 + B220 int-hi IgD lo splenic B cells at various timepoints p.i. to perform droplet-based, paired single cell RNA and BCR sequencing. (B) Annotated combined UMAP of all mice, treatments and timepoints after high-dimensional reduction and clustering (left), with quantitation (right) of the proportion of selected, annotated B cells over the course of Pc AS infection (no drug treatment). (C) Sub-clustering of the GC cluster identifies distinct DZp, DZd, LZ/DZ and LZ GC B cell clusters as indicated in the dot plot of canonical markers and gene signatures of known GC B cell subsets. Also shown is quantitation of different GC B cell populations over time. RCTD spatial deconvolution of GC B cell populations on a day 30, Plasmodium infected spleen using Slide-seqV2 spatial transcriptomics (right). (D) Median Aicda gene expression in GC B cell subsets and naive B cells as negative control. (E) Median Aicda expression shown overtime, with or without anti-malarial treatment in DZd and DZp GC B cells. (F) Somatic hypermutation analysis of GC B cell BCRs and isotype usage overtime, split by treatment, showing mutation rates for both treatments. Median number of mutations for each treatment and timepoint indicated in white. Data in B-C are shown as mean ± S.D. and analysed by one-way ANOVA with Tukey’s multiple comparisons test of n = 3 biological replicates. * p < 0.05.

Journal: bioRxiv

Article Title: Temporally overlapping mechanisms diversify clonal B cell responses in vivo

doi: 10.1101/2024.12.17.628863

Figure Lengend Snippet: (A) Experimental plan to study B cell differentiation in Pc AS-infected mice, with or without anti-malarial drug treatment, sorting CD19 + B220 int-hi IgD lo splenic B cells at various timepoints p.i. to perform droplet-based, paired single cell RNA and BCR sequencing. (B) Annotated combined UMAP of all mice, treatments and timepoints after high-dimensional reduction and clustering (left), with quantitation (right) of the proportion of selected, annotated B cells over the course of Pc AS infection (no drug treatment). (C) Sub-clustering of the GC cluster identifies distinct DZp, DZd, LZ/DZ and LZ GC B cell clusters as indicated in the dot plot of canonical markers and gene signatures of known GC B cell subsets. Also shown is quantitation of different GC B cell populations over time. RCTD spatial deconvolution of GC B cell populations on a day 30, Plasmodium infected spleen using Slide-seqV2 spatial transcriptomics (right). (D) Median Aicda gene expression in GC B cell subsets and naive B cells as negative control. (E) Median Aicda expression shown overtime, with or without anti-malarial treatment in DZd and DZp GC B cells. (F) Somatic hypermutation analysis of GC B cell BCRs and isotype usage overtime, split by treatment, showing mutation rates for both treatments. Median number of mutations for each treatment and timepoint indicated in white. Data in B-C are shown as mean ± S.D. and analysed by one-way ANOVA with Tukey’s multiple comparisons test of n = 3 biological replicates. * p < 0.05.

Article Snippet: Spatial transcriptomics was performed using Slide-seqV2 at the Broad Institute of Harvard and MIT, as described elsewhere .

Techniques: Cell Differentiation, Infection, Sequencing, Quantitation Assay, Expressing, Negative Control, Mutagenesis

(A) scVI integration of our day 10-42 B cell dataset with publicly available scRNAseq bone marrow data combined and split by each dataset, with arrow indicating inferred trajectory of Lee et al., 2021 dataset. (B) Annotated B cell scVI integrated UMAP (experiment 1 and experiment 2) of specific precursor B cell subsets during extramedullary B lymphopoiesis: pro-, cycling pro-, pre- and immature B cells split overtime, with or without anti-malarial drug treatment and quantified per replicate mouse. (C) Il7r gene expression highlighted on proB and preB cells. IL7R surface marker used to identify precursor B cells shown by representative flow cytometry panel of B cells gated on CD45.2 - (intravenous label negative, IV - ), CD19 + B220 + CD138 - CD38 + Fas - IgD - CD93 + for immature B cells (IgM + IL7R - ), pro-B cells (IgM - IL7R + , CD43 hi CD24 int ) and pre-B cells (IgM - IL7R + , CD43 int CD24 hi ) in uninfected mice and at day 21 post- Pc AS infection, with quantitation of splenic precursor B cells at 0, 14 and 21 days p.i. (D) RCTD spatial deconvolution of immature B cell populations from Plasmodium infected spleen at day 30 p.i. using Slide-seqV2 spatial transcriptomics, showing spearman’s correlation analysis of cell co-localisations from a scRNAseq reference with location of selected populations including immature B cells (green) plotted on the array. (E) Schematic of different B cell dynamics including extramedullary B lymphopoiesis (EMBL) in our Plasmodium infection system. Lines in panel B connect the mean values at each timepoint and analysed by Welch’s t -test and panel C by one-way ANOVA with multiple comparisons test of n = 10-20 pooled from 2 independent experiments. Data in panel C are the mean value. * p < 0.05, *** p < 0.001, **** p < 0.0001. ns, not significant.

Journal: bioRxiv

Article Title: Temporally overlapping mechanisms diversify clonal B cell responses in vivo

doi: 10.1101/2024.12.17.628863

Figure Lengend Snippet: (A) scVI integration of our day 10-42 B cell dataset with publicly available scRNAseq bone marrow data combined and split by each dataset, with arrow indicating inferred trajectory of Lee et al., 2021 dataset. (B) Annotated B cell scVI integrated UMAP (experiment 1 and experiment 2) of specific precursor B cell subsets during extramedullary B lymphopoiesis: pro-, cycling pro-, pre- and immature B cells split overtime, with or without anti-malarial drug treatment and quantified per replicate mouse. (C) Il7r gene expression highlighted on proB and preB cells. IL7R surface marker used to identify precursor B cells shown by representative flow cytometry panel of B cells gated on CD45.2 - (intravenous label negative, IV - ), CD19 + B220 + CD138 - CD38 + Fas - IgD - CD93 + for immature B cells (IgM + IL7R - ), pro-B cells (IgM - IL7R + , CD43 hi CD24 int ) and pre-B cells (IgM - IL7R + , CD43 int CD24 hi ) in uninfected mice and at day 21 post- Pc AS infection, with quantitation of splenic precursor B cells at 0, 14 and 21 days p.i. (D) RCTD spatial deconvolution of immature B cell populations from Plasmodium infected spleen at day 30 p.i. using Slide-seqV2 spatial transcriptomics, showing spearman’s correlation analysis of cell co-localisations from a scRNAseq reference with location of selected populations including immature B cells (green) plotted on the array. (E) Schematic of different B cell dynamics including extramedullary B lymphopoiesis (EMBL) in our Plasmodium infection system. Lines in panel B connect the mean values at each timepoint and analysed by Welch’s t -test and panel C by one-way ANOVA with multiple comparisons test of n = 10-20 pooled from 2 independent experiments. Data in panel C are the mean value. * p < 0.05, *** p < 0.001, **** p < 0.0001. ns, not significant.

Article Snippet: Spatial transcriptomics was performed using Slide-seqV2 at the Broad Institute of Harvard and MIT, as described elsewhere .

Techniques: Expressing, Marker, Flow Cytometry, Infection, Quantitation Assay

RCTD spatial deconvolution of immature B cell populations (highlighted in purple) on spatial transcriptomic arrays using Slide-seqV2 and analysed using spearman’s correlation analysis as in . These arrays are replicates for data shown in , and combined they comprise two arrays per spleen from two infected mice.

Journal: bioRxiv

Article Title: Temporally overlapping mechanisms diversify clonal B cell responses in vivo

doi: 10.1101/2024.12.17.628863

Figure Lengend Snippet: RCTD spatial deconvolution of immature B cell populations (highlighted in purple) on spatial transcriptomic arrays using Slide-seqV2 and analysed using spearman’s correlation analysis as in . These arrays are replicates for data shown in , and combined they comprise two arrays per spleen from two infected mice.

Article Snippet: Spatial transcriptomics was performed using Slide-seqV2 at the Broad Institute of Harvard and MIT, as described elsewhere .

Techniques: Infection